Equities research analysts expect that West Pharmaceutical Services Inc. (NYSE:WST) will post earnings of $0.66 per share for the current quarter, according to Zacks. Three analysts have issued estimates for West Pharmaceutical Services’ earnings. The highest EPS estimate is $0.68 and the lowest is $0.64. West Pharmaceutical Services posted earnings of $0.60 per share during the same quarter last year, which would indicate a positive year over year growth rate of 10%. The firm is scheduled to report its next earnings results on Thursday, April 26th.
On average, analysts expect that West Pharmaceutical Services will report full-year earnings of $2.84 per share for the current fiscal year, with EPS estimates ranging from $2.79 to $2.90. For the next year, analysts expect that the company will report earnings of $3.27 per share, with EPS estimates ranging from $3.20 to $3.40. Zacks’ EPS averages are an average based on a survey of sell-side research firms that follow West Pharmaceutical Services.
West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, February 15th. The medical instruments supplier reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.02. The business had revenue of $415.60 million during the quarter, compared to analyst estimates of $416.90 million. West Pharmaceutical Services had a return on equity of 14.68% and a net margin of 9.42%. West Pharmaceutical Services’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.54 earnings per share.
A number of institutional investors have recently added to or reduced their stakes in WST. State Board of Administration of Florida Retirement System raised its stake in West Pharmaceutical Services by 4.3% during the third quarter. State Board of Administration of Florida Retirement System now owns 92,082 shares of the medical instruments supplier’s stock worth $8,864,000 after acquiring an additional 3,830 shares in the last quarter. Stevens Capital Management LP acquired a new position in West Pharmaceutical Services during the third quarter worth $947,000. Swiss National Bank raised its stake in West Pharmaceutical Services by 0.8% during the third quarter. Swiss National Bank now owns 123,000 shares of the medical instruments supplier’s stock worth $11,840,000 after acquiring an additional 1,000 shares in the last quarter. Bessemer Group Inc. raised its stake in West Pharmaceutical Services by 4.8% during the third quarter. Bessemer Group Inc. now owns 12,510 shares of the medical instruments supplier’s stock worth $1,204,000 after acquiring an additional 578 shares in the last quarter. Finally, Jennison Associates LLC raised its stake in West Pharmaceutical Services by 54.6% during the third quarter. Jennison Associates LLC now owns 668,023 shares of the medical instruments supplier’s stock worth $64,304,000 after acquiring an additional 236,022 shares in the last quarter. Hedge funds and other institutional investors own 94.37% of the company’s stock.
West Pharmaceutical Services (NYSE WST) opened at $92.01 on Tuesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.66 and a quick ratio of 1.89. The company has a market capitalization of $6,809.72, a price-to-earnings ratio of 46.24, a P/E/G ratio of 2.28 and a beta of 1.15. West Pharmaceutical Services has a 12 month low of $77.97 and a 12 month high of $103.36.
West Pharmaceutical Services declared that its board has initiated a stock repurchase program on Thursday, February 15th that authorizes the company to buyback 800,000 shares. This buyback authorization authorizes the medical instruments supplier to repurchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 2nd. Shareholders of record on Wednesday, April 18th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Tuesday, April 17th. This represents a $0.56 annualized dividend and a yield of 0.61%. West Pharmaceutical Services’s dividend payout ratio is currently 28.14%.
COPYRIGHT VIOLATION NOTICE: “$0.66 Earnings Per Share Expected for West Pharmaceutical Services Inc. (WST) This Quarter” was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.americanbankingnews.com/2018/03/13/0-66-earnings-per-share-expected-for-west-pharmaceutical-services-inc-wst-this-quarter.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.